|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02410 TYK MEDICINES-B
Nominal 
19.060 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (308,252) | (200,944) | (220,053) |
| Net Cash from / (used in) Investing Activities | (135,858) | 73,008 | (158,165) |
| Net Cash from / (used in) Financing Activities | 632,080 | 223,997 | 351,139 |
| Increase / (Decrease) in Cash & Cash Equivalents | 187,970 | 96,061 | (27,079) |
| Cash & Cash Equivalents at beginning of period | 186,830 | 90,762 | 117,841 |
| Effect of Foreign Exchange Rate Changes | 246 | 7 | 0 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 375,046 | 186,830 | 90,762 |
| Remarks: | Real time quote last updated: 21/07/2025 08:28 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -386,955 |
| %Change | 1.184% |
| EPS / (LPS) | RMB -1.150 |
| NBV Per Share (¥) | RMB 1.265 |